Sysmex Nordic is excited to announce its selection to deliver state-of-the-art diagnostic solutions for haemostasis for seven hospital laboratories in the Region of Southern Denmark. The contract demonstrates Sysmex Nordic’s dedication to improving patient care through accurate and accelerated diagnostics results.
The commitment is part of a Total Lab Automation (TAL) tender contract awarded to Roche Diagnostics with Sysmex as a sub-contractor.
‘We are proud and honoured to be chosen for this contract,’ says Sven Dohmann, General Manager of Sysmex Nordic. ‘This is a testament to our commitment to innovation and quality in diagnostics and reflects the work and dedication of our teams.’
Dohmann continues, ‘We look forward to further developing our partnerships with Roche Diagnostics and healthcare providers in the Region of Southern Denmark, contributing to improved patient management and improved treatment in the coming years.’
To further strengthen its ongoing expansion, Sysmex Nordic has recently launched a new growth strategy focusing on new product lines and market segments.
One key area of focus is haemostasis, involving the analysis of blood samples for diagnosing bleeding disorders, such as haemophilia A and B, and thrombophilia disorders, like antithrombin, protein C and protein S. For the solutions that will be delivered to laboratories in the Region of Southern Denmark the local teams will provide product training, installation, and application support as well as ongoing service during operation.
The strategic direction underscores Sysmex Nordic's focus on increasing lab efficiency, providing accurate diagnostics, and improving patient management among healthcare providers in Denmark and the broader Nordic region.
